FDA advisory panel to vote on Pfizer COVID booster shot

An FDA advisory committee will meet today to discuss the safety and efficacy of Pfizer’s booster vaccine. The move comes as debate heats up over who should receive a third dose to protect against the coronavirus, and when. Ed O’Keefe reports. Source